Mark T. Bertolini is the Chief Executive Officer of Oscar Health, a leading healthcare technology company dedicated to making a healthier life accessible and affordable for all.
Mark is former Co-Chief Executive Officer of Bridgewater Associates, the world’s largest and most successful hedge fund.
Mark is also a national health care thought leader, and the former Chairman and CEO of Aetna Inc. At Aetna, Mark assumed the role of CEO in November 2010, and of Chairman in April 2011. In November 2018, he stepped down as Chairman and CEO and served as a Director of CVS Health Corporation upon completion of CVS Health’s acquisition of Aetna, valued at $69 billion. Throughout Mark’s tenure at Aetna, he led the company’s transition from a traditional health insurance company to a consumer-oriented health care company focused on delivering holistic, integrated care in local communities.
Before joining Aetna, Mark held executive positions at Cigna, NYLCare Health Plans, and SelectCare, Inc., where he was President and Chief Executive Officer. He serves as a director of Verizon Communications Inc. (communications and technology solutions), Thrive Global (sustainable, science-based solutions to enhance well-being, performance and purpose), and the FIDELCO Guide Dog Foundation (non-profit organization that breeds, trains and places German Shepherd guide dogs with people who have visual disabilities).
What is Mark T. Bertolini's net worth?
The estimated net worth of Mark T. Bertolini is at least $268.53 million as of June 25th, 2026. Mr. Bertolini owns 9,581,734 shares of Oscar Health stock worth more than $268,528,095 as of June 30th. This net worth approximation does not reflect any other assets that Mr. Bertolini may own. Learn More about Mark T. Bertolini's net worth.
How do I contact Mark T. Bertolini?
Has Mark T. Bertolini been buying or selling shares of Oscar Health?
During the past quarter, Mark T. Bertolini has bought $11,920,000.00 in shares of Oscar Health stock and sold $34,908,611.66 in shares of Oscar Health stock. Most recently, Mark T. Bertolini sold 591,168 shares of the business's stock in a transaction on Friday, June 26th. The shares were sold at an average price of $29.28, for a transaction totalling $17,309,399.04. Following the completion of the sale, the chief executive officer now directly owns 8,990,566 shares of the company's stock, valued at $263,243,772.48. Learn More on Mark T. Bertolini's trading history.
Who are Oscar Health's active insiders?
Oscar Health's insider roster includes Victoria Baltrus (CAO), Mark Bertolini (CEO), Richard Blackley (CFO), Ranmali Bopitiya (EVP), Meghan Joyce (COO), Joshua Kushner (Vice Chairman), Janet Liang (Insider), Adam Mcananey (Insider), Alessandrea Quane (EVP), Elbert Robinson, Jr. (Director), Sid Sankaran (Director), Mario Schlosser (CEO), Dennis Weaver (Insider), and Steven Wolin (COO). Learn More on Oscar Health's active insiders.
Are insiders buying or selling shares of Oscar Health?
During the last twelve months, Oscar Health insiders bought shares 1 times. They purchased a total of 1,000,000 shares worth more than $11,920,000.00. During the last twelve months, insiders at the sold shares 19 times. They sold a total of 3,301,777 shares worth more than $84,294,851.62. The most recent insider tranaction occured on June, 26th when CEO Mark T Bertolini sold 591,168 shares worth more than $17,309,399.04. Insiders at Oscar Health own 25.1% of the company.
Learn More about insider trades at Oscar Health. Information on this page was last updated on 6/26/2026.
